Literature DB >> 16420726

Effectiveness of different policies in preventing meningococcal disease clusters following a single case in day-care and pre-school settings in Europe.

D Boccia1, N Andrews, S Samuelsson, S Heuberger, A Perrocheau, J M Stuart.   

Abstract

National policies for chemoprophylaxis after single cases of meningococcal disease in day-care or nursery settings vary across Europe. We carried out a multi-national retrospective study to compare the effectiveness of different policies. Countries were divided into those recommending chemoprophylaxis only to close contacts (policy A, close) and those recommending chemoprophylaxis for all children in the same nursery (policy B, mass). Country-specific relative risk (RR) of a cluster was defined as the ratio of the number of clusters observed to the number of clusters expected by chance. In total, 37 clusters were identified between 1 January 1993 and 31 December 2002. After adjusting for marked heterogeneity in RR by country, the ratio of RR between countries suggested possible benefit from mass prophylaxis (RR ratio 3.8, 95% CI 0.7-22.0), although the difference was not statistically significant (P=0.22). The costs of this approach and the low risk of clustering need to be taken into account when deciding national policy.

Entities:  

Mesh:

Year:  2006        PMID: 16420726      PMCID: PMC2870467          DOI: 10.1017/S0950268805005819

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide?

Authors:  A Round; S Palmer
Journal:  J Public Health Med       Date:  1999-03

2.  Antibiotic prophylaxis for bacterial meningitis: overuse and uncertain efficacy.

Authors:  N Pearson; D J Gunnell; C Dunn; T Beswick; A Hill; B Ley
Journal:  J Public Health Med       Date:  1995-12

3.  A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings.

Authors:  L Hastings; J Stuart; N Andrews; N Begg
Journal:  Commun Dis Rep CDR Rev       Date:  1997-12-12

4.  School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis.

Authors:  K M Zangwill; A Schuchat; F X Riedo; R W Pinner; D T Koo; M W Reeves; J D Wenger
Journal:  JAMA       Date:  1997-02-05       Impact factor: 56.272

5.  Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.

Authors:  P Yagupsky; S Ashkenazi; C Block
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

6.  Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk?

Authors:  K L Davison; N Andrews; J M White; M E Ramsay; N S Crowcroft; A A Rushdy; E B Kaczmarski; P N Monk; J M Stuart
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

Review 7.  Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.

Authors:  Bernadette Purcell; Susanne Samuelsson; Susan J M Hahné; Ingrid Ehrhard; Sigrid Heuberger; Ivonne Camaroni; André Charlett; James M Stuart
Journal:  BMJ       Date:  2004-06-05

8.  Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.

Authors:  R Gold; I Goldschneider; M L Lepow; T F Draper; M Randolph
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

  8 in total
  2 in total

1.  Cluster of three cases of invasive meningococcal disease in a preschool facility in West Bohemia, the Czech Republic.

Authors:  P Pazdiora; I Morávková; T Bergerová; V Struncová; P Křížová; M Musílek; C Beneš
Journal:  Folia Microbiol (Praha)       Date:  2012-08-11       Impact factor: 2.099

Review 2.  Strong Public Health Recommendations from Weak Evidence? Lessons Learned in Developing Guidance on the Public Health Management of Meningococcal Disease.

Authors:  Germaine Hanquet; Pawel Stefanoff; Wiebke Hellenbrand; Sigrid Heuberger; Pierluigi Lopalco; James M Stuart
Journal:  Biomed Res Int       Date:  2015-11-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.